Want to see IT:EUK full AI Analyst Report?
EUK Stock Chart & Stats
€0.72
-€0.02(-2.41%)
At close: 4:00 PM EST
€0.72
-€0.02(-2.41%)
Day’s Range― - ―
52-Week Range€0.45 - €0.82
Previous CloseN/A
Volume1.70K
Average Volume (3M)4.68K
Market Cap
€15.24M
Enterprise Value€142.65M
Total Cash (Recent Filing)€416.00K
Total Debt (Recent Filing)€128.29M
Price to Earnings (P/E)―
Beta0.31
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding22,741,629
10 Day Avg. Volume3,064
30 Day Avg. Volume4,678
Financial Highlights & Ratios
PEG Ratio-0.50
Price to Book (P/B)0.55
Price to Sales (P/S)0.31
P/FCF Ratio36.77
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Bulls Say, Bears Say
Bulls Say
Contractual, Fee-based Business ModelEukedos’s core revenue comes from contracted service fees and public/private reimbursements, creating structurally recurring cash flows tied to care delivery demand. This business model provides revenue predictability and demand insulation from cyclical industries given aging populations and long-term care needs.
Resilient Operating MarginsStable mid-single-digit EBIT and healthy EBITDA margins indicate durable operational control and scale in facility-based care. Consistent operating profitability supports capacity to cover fixed costs, maintain service quality, and potentially fund targeted investments even when net income fluctuates.
Consistent Positive Operating Cash FlowPositive operating cash generation over multiple years underpins ongoing operations and working-capital needs, helping service interest and short-term obligations. Reliable OCF provides a structural buffer versus earnings volatility and supports continuity of care and incremental reinvestment when prioritized.
Bears Say
Very High LeverageExtremely high debt relative to equity materially reduces financial flexibility and heightens interest-rate and refinancing vulnerability. With a small equity cushion, even modest operational setbacks could strain covenants or force costly refinancing, constraining capital allocation and strategic options over the medium term.
Returned To Net LossesNet losses in recent years weaken retained earnings and erode equity, increasing dependence on external financing. Persistent or recurring losses can impair lender confidence, raise borrowing costs, and limit the company’s capacity to invest in facility upgrades or expansion needed to sustain long-term competitiveness.
Volatile And Weak Free Cash FlowHighly variable free cash flow undermines the company’s ability to deleverage, fund capex, or absorb shocks. With elevated debt, inconsistent FCF raises refinancing and liquidity risk, potentially forcing asset sales, deferred maintenance, or covenant concessions that hurt long-term service capacity and margin sustainability.
Eukedos S.p.A. News
EUK FAQ
What was Eukedos S.p.A.’s price range in the past 12 months?
Eukedos S.p.A. lowest stock price was €0.45 and its highest was €0.82 in the past 12 months.
What is Eukedos S.p.A.’s market cap?
Eukedos S.p.A.’s market cap is €15.24M.
When is Eukedos S.p.A.’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were Eukedos S.p.A.’s earnings last quarter?
Currently, no data Available
Is Eukedos S.p.A. overvalued?
According to Wall Street analysts Eukedos S.p.A.’s price is currently Overvalued.
Does Eukedos S.p.A. pay dividends?
Eukedos S.p.A. pays a Notavailable dividend of €0.044 which represents an annual dividend yield of N/A. See more information on Eukedos S.p.A. dividends here
What is Eukedos S.p.A.’s EPS estimate?
Eukedos S.p.A.’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Eukedos S.p.A. have?
Eukedos S.p.A. has 22,741,629 shares outstanding.
What happened to Eukedos S.p.A.’s price movement after its last earnings report?
Currently, no data Available
Which hedge fund is a major shareholder of Eukedos S.p.A.?
Currently, no hedge funds are holding shares in IT:EUK
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Company Description
Eukedos S.p.A.
EuKedos S.p.A. operates in Italy, offering a range of managed and long-term care provisions. The company specializes in delivering residential social support for older adults, catering to both independent individuals and those needing extensive assistance. With 1,345 beds, it oversees healthcare and residential care facilities throughout northern and central Italy, notably in regions such as Lombardy, Piedmont, Abruzzo, Valle D'Aosta, and Emilia Romagna. EuKedos S.p.A. is headquartered in Florence, Italy.
Technical Analysis
Arterra Bioscience SpA
―
Farmacosmo S.P.A.
―
Svas Biosana S.p.A.
―
I.M.D. International Medical Devices S.P.A.
―
Piu Medical S.P.A.
―